71,1 %Day 28 adequate clinical and parasitological response for artemether-lumefantrine was 71.1% (59/83) with 95% CI 60.4–79.9.
Nigeriapaludismepublié 2023Malaria journaleurope_pmcdocument de 12 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
2 070 evidences · page 22 / 83
71,1 %Day 28 adequate clinical and parasitological response for artemether-lumefantrine was 71.1% (59/83) with 95% CI 60.4–79.9.
Nigeriapaludismepublié 2023Malaria journaleurope_pmcdocument de 12 observations
18,2 %The overall prevalence of the Pfmdr1 86Y mutant form was 18.2% (95% CI: 12.0–25.8%).
Nigeriapaludismepublié 2021Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genPubMeddocument de 16 observations
80 %Overall, 320 out of 400 pregnant women took sulphadoxine-pyrimethamine for intermittent preventive treatment in pregnancy (IPTp-SP), representing 80.0% coverage.
Nigeriapaludismepublié 2019The Pan African medical journalPubMeddocument de 9 observations
56,5 %56.5% of pregnant women received at least one intermittent preventive therapy (IPT) for malaria.
Nigeriapaludismepublié 2020The journal of maternal-fetal & neonatal medicine : the official journal of the European APubMeddocument de 8 observations
11,4 %The prevalence of severe malaria among admissions was 11.4% in the pre-COVID-19 period and 17.3% in the COVID-19 period.
Nigeriapaludismeobservé 2019, 2020publié 2022Impact of COVID-19 on outcomes of childhood severe malaria: A comparative of study pre-COVeurope_pmcdocument de 6 observationsDOI 10.21203/rs.3.rs-2004891/v1
2,01 μg/mLLes extraits méthanoliques de Citrullus colocynthis présentent un IC50 de 2,01 μg/mL sur la souche 3D7 de Plasmodium falciparum et de 6,9 μg/mL sur la souche K1.
Nigeriapaludismeobservé 2017HAL · Unilimdocument de 173 observations
38,6 %Malaria prevalence was 38.6% by microscopic test in rural communities of Ebonyi State, Nigeria.
Nigeriapaludismepublié 2022The Korean journal of parasitologyPubMeddocument de 10 observations
11,67 %Malaria RDT result was positive in 7/60 (11.67%) of the first-line cART experienced HIV-infected participants.
Nigeriapaludisme · VIH/sidaobservé 2018–2019publié 2024BMC infectious diseasesPubMeddocument de 15 observations
120 patientsDuring follow-up, 120 patients developed patent gametocytaemia.
Nigeriapaludismepublié 2004Parasitologyeurope_pmcdocument de 10 observations
4,9 odds_ratioA child is five times more likely to die from severe malaria in the COVID-19 era than in the pre-COVID era (odds ratio = 4.9, 95% CI 2.008–11.982).
Nigeriapaludismeobservé 2019, 2020publié 2022Impact of COVID-19 on outcomes of childhood severe malaria: A comparative of study pre-COVeurope_pmcdocument de 6 observationsDOI 10.21203/rs.3.rs-2004891/v1
2 092,5 parasite/μLThe age group >60 years recorded the highest mean malaria parasite density of 2092.50 parasite/μL of blood.
Nigeriapaludismepublié 2021Tropical biomedicinePubMeddocument de 6 observations
268 isolatesHigh-quality amplification was achieved for 268 of 299 archived Plasmodium falciparum patient isolates collected in Awka (n = 200) and Onitsha (n = 99), South-East Nigeria (2018–2019).
Nigeriapaludismeobservé 2018-2019publié 2025Malaria journalPubMeddocument de 4 observations
60,8 %Adequate intermittent preventive treatment (IPTp) uptake (≥3 doses) was 60.8% in the rural areas of Ebonyi State.
Nigeriapaludismepublié 2022PloS onePubMeddocument de 5 observations
74 participantsThe study included 74 participants: 20 apparently healthy controls and 54 COVID-19 patients, of whom 34 were co-infected with malaria.
NigeriaCOVID-19 · paludismepublié 2020The Pan African medical journalPubMeddocument de 3 observations
21 %Peripheral parasitaemia was present in 16 of 73 newborn babies, representing 21 per cent.
Nigeriapaludismepublié 1996Journal of Obstetrics and GynaecologyOpenAlexdocument de 5 observations
85,8 %85.8% of caregivers of under-5 children in Asaba, Delta State, Nigeria were willing to vaccinate their children with the R21/Matrix-M malaria vaccine.
Nigeriapaludismeobservé 2025publié 2026Malaria journalPubMeddocument de 5 observations
44,3 %The prevalence of single dhps haplotype mutation (SGKAA) was 44.3% among samples from individuals with malaria in Lagos, Nigeria.
Nigeriapaludismepublié 2020Infectious diseases of povertyeurope_pmcdocument de 4 observationsDOI 10.1186/s40249-020-00712-4
54 %Co-infection with malaria parasitaemia was detected in 54% of the study population.
Nigeriapaludismeobservé July 2016 to October 2018publié 2020Le infezioni in medicinaPubMeddocument de 8 observations
100 %The specificity of microscopic examination for malaria diagnosis was 100%.
Nigeriapaludismepublié 2022The Korean journal of parasitologyPubMeddocument de 10 observations
90,9 %The PCR adjusted parasitological cure rate was 90.9% in Nigeria.
Nigeriapaludismepublié 2008Malaria journaleurope_pmcdocument de 9 observationsDOI 10.1186/1475-2875-7-190
0,2 frequencyA relatively low frequency (0.2) of the G119S mutation was found in Anopheles coluzzii in Ebonyi State.
Nigeriapaludismeobservé 2016publié 2020Parasites & vectorsPubMeddocument de 3 observations
4,1 μg/mLDc fraction exhibited an IC50 of 4.1 ± 0.1 μg/mL against Plasmodium falciparum 7G8 strain.
NigeriapaludismeHAL · Unilimdocument de 39 observations
2 daysAt enrolment, parasite clearance time ⩾2 days was an independent risk factor for subsequent recrudescence of primary infections, with adjusted odds ratio 2.47.
Nigeriapaludismepublié 2011Asian Pacific Journal of Tropical DiseaseOpenAlexdocument de 6 observations
0,064 heterozygosity_indexThe heterozygosity (He) index for Plasmodium falciparum populations was 0.0636.
Nigeriapaludismepublié 2021Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genPubMeddocument de 5 observations
18,1 %Malaria antigenaemia prevalence was 18.1% in HIV-negative controls.
Nigeriapaludismeobservé April to June 2016publié 2022West African journal of medicinePubMeddocument de 6 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.